PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
51 hedge funds and large institutions have $73.4M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 20 closing their positions.
Holders
51
Holders Change
-10
Holders Change %
-16.39%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
15
Closed
20
Calls
$275K
Puts
$138K
Net Calls
+$137K
Net Calls Change
+$202K
